iRay Technology Co Ltd
SSE:688301
Net Margin
iRay Technology Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
iRay Technology Co Ltd
SSE:688301
|
18.6B CNY |
26%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
229.6B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
199.4B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.7B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.5B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.5B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.8B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.7B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.5B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.5B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
276.1B CNY |
31%
|
iRay Technology Co Ltd
Glance View
iRay Technology Co., Ltd., founded in China in 2011, has swiftly emerged as a pivotal player in the realm of X-ray imaging technology. Harnessing a potent blend of innovation and scientific expertise, the company specializes in developing and manufacturing advanced digital X-ray detectors. iRay's cutting-edge detectors are a core component in medical imaging systems, providing clear, high-resolution images that are crucial for accurate diagnostics. As global healthcare standards evolve, the demand for high-quality medical imaging solutions burgeons, positioning iRay as a vital contributor to the modernization of healthcare infrastructure. By capitalizing on technological advancements and the relentless pursuit of precision, iRay ensures its products meet the stringent demands of both domestic and international markets. iRay Technology's business model thrives on its ability to consistently deliver superior-quality imaging solutions while expanding its footprint across diverse sectors. Beyond healthcare, iRay's detectors find applications in industrial non-destructive testing and security inspection, diversifying its revenue streams. The company invests significantly in research and development to maintain its technological edge, aiming to drive innovations that enhance imaging performance and cost-efficiency. This investment in R&D not only fuels product enhancements but also cements iRay’s competitive advantage in a rapidly changing industry. By leveraging a robust sales and distribution network, coupled with strategic partnerships, iRay effectively capitalizes on expanding market opportunities, thereby solidifying its revenue base and ensuring sustainable growth.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on iRay Technology Co Ltd's most recent financial statements, the company has Net Margin of 25.7%.
You don't have any saved screeners yet